| Course | NS455 Current Trends in Nutrition |
|---|---|
| Unit | Unit 7 |
| Paper type | Annotated bibliography |
| Length | About 920 words, 6 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | BS in Nutrition Science |
| Updated | October 2026 |
Free sample paper for NS455 Unit 7
After the Erythritol Headlines: A Unit 7 Annotated Bibliography of Eight Sources on Sugar Substitutes and Heart Risk
[Student Name]
Purdue University Global
NS455: Current Trends in Nutrition
Unit 7 Annotated Bibliography
[Instructor Name]
[Date]
The planned paper is the student's own; all eight sources annotated are real.
Purpose and Scope
The planned paper asks whether current evidence supports advising adults at risk of heart disease to avoid sugar substitutes, especially sugar alcohols such as erythritol. Sources were chosen to cover each kind of evidence the question needs: cohort studies, mechanistic work, a systematic review, a guideline and context on how the body makes erythritol itself. They are listed alphabetically by first author.
Annotations
Debras, C., et al. (2022). This French cohort followed more than 100,000 adults and estimated artificial sweetener intake from repeated 24-hour dietary records. Higher total intake was associated with a 9 percent higher risk of cardiovascular disease, and aspartame with cerebrovascular events in particular (Debras et al., 2022). Strength: detailed, repeated intake data rather than one questionnaire. Limit: observational, so people who use sweeteners may differ in ways that adjustment misses, such as existing weight concerns. Use in paper: the main cohort evidence for intense sweeteners, kept separate from sugar alcohols.
Hootman, K. C., et al. (2017). This metabolomics study of young adults found that blood erythritol was higher in those who gained abdominal fat, and isotope tracer work showed the body makes erythritol from glucose (Hootman et al., 2017). Strength: shows an internal source of erythritol. Limit: small sample and not about diet. Use in paper: essential context, because it means high blood erythritol may reflect metabolism rather than intake, which complicates any cohort that measures blood levels.
Mazi, T. A., & Stanhope, K. L. (2023). A narrative review of erythritol's absorption, metabolism and possible benefits and risks. Strength: brings together evidence on how erythritol is handled by the body. Limit: a narrative review, so sources were not chosen systematically (Mazi & Stanhope, 2023). Use in paper: background on metabolism, cited for description rather than for conclusions about risk.
Rios-Leyvraz, M., & Montez, J. (2022). The systematic review commissioned to inform the WHO guideline. It pooled trials and cohorts and found no clear long-term benefit of non-sugar sweeteners for body weight in adults, with some cohorts linking regular use to more type 2 diabetes and more heart and stroke events (Rios-Leyvraz & Montez, 2022). Strength: up to date and broad, with explicit certainty ratings. Limit: like the guideline it informs, it does not cover sugar alcohols, and its harm findings come from observational data. Use in paper: the evidence base behind official advice, read alongside Toews to show how two reviews of similar studies can frame the same uncertainty differently.
Toews, I., et al. (2019). A systematic review and meta-analysis of 56 studies on non-sugar sweeteners in healthy people. Most outcomes showed no clear difference between use and non-use, and certainty was low or very low throughout (Toews et al., 2019). Strength: systematic methods and certainty ratings. Limit: few long trials and almost nothing on sugar alcohols or cardiovascular events. Use in paper: shows how thin the controlled evidence is.
No source in this list is a long controlled trial of erythritol and heart events, so the paper will have to argue from converging but indirect evidence and say so plainly.
Witkowski, M., et al. (2023). The paper behind the headlines. Among patients undergoing cardiac evaluation in the United States and Europe, those in the highest quarter of blood erythritol had about 1.8 to 2.2 times the risk of heart attack, stroke or death over three years compared with the lowest quarter. Laboratory work showed erythritol made platelets more reactive, and eight volunteers who drank an erythritol beverage had blood levels high enough to do so for more than two days (Witkowski et al., 2023). Strength: combines cohort, laboratory and human feeding data. Limit: the cohorts were already at high cardiac risk, and blood erythritol was not linked to measured intake. Use in paper: the central source, presented with its limits.
Witkowski, M., et al. (2024). The same group found a similar association for xylitol, another sugar alcohol, and similar effects on platelets (Witkowski et al., 2024). Strength: replication of the method for a second compound. Limit: same design limits and the same research group. Use in paper: shows the concern may extend beyond erythritol, while noting it is not independent replication.
World Health Organization. (2023). A guideline recommending that non-sugar sweeteners not be used for weight control, based on a systematic review that found no long-term benefit for body fat and possible links with type 2 diabetes and cardiovascular disease in observational studies (World Health Organization, 2023). Strength: formal guideline process. Limit: the recommendation is conditional, and it excludes sugar alcohols such as erythritol from its scope. Use in paper: shows where official advice stands, and that it does not yet address erythritol.
How the Sources Fit Together
The cohort studies, Witkowski 2023 and Debras 2022, raise concern, and the WHO review adds broader observational signals. The mechanistic work explains how harm could occur. Hootman shows why blood levels may mislead. Toews and the guideline show that controlled evidence is limited. Together they support cautious advice for people at high cardiac risk while making clear that causation has not been shown.
Sources Still Needed
A trial measuring dietary erythritol intake against cardiovascular outcomes would close the gap; none was found. The paper will also look for any updated regulatory reviews of erythritol's safety.
References
Debras, C., Chazelas, E., Sellem, L., Porcher, R., Druesne-Pecollo, N., Esseddik, Y., de Edelenyi, F. S., Agaësse, C., De Sa, A., Lutchia, R., Fezeu, L. K., Julia, C., Kesse-Guyot, E., Allès, B., Galan, P., Hercberg, S., Deschasaux-Tanguy, M., Huybrechts, I., Srour, B., & Touvier, M. (2022). Artificial sweeteners and risk of cardiovascular diseases: Results from the prospective NutriNet-Santé cohort. BMJ, 378, e071204. https://doi.org/10.1136/bmj-2022-071204
Hootman, K. C., Trezzi, J.-P., Kraemer, L., Burwell, L. S., Dong, X., Guertin, K. A., Jaeger, C., Stover, P. J., Hiller, K., & Cassano, P. A. (2017). Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults. Proceedings of the National Academy of Sciences, 114(21), E4233-E4240. https://doi.org/10.1073/pnas.1620079114
Mazi, T. A., & Stanhope, K. L. (2023). Erythritol: An in-depth discussion of its potential to be a beneficial dietary component. Nutrients, 15(1), 204. https://doi.org/10.3390/nu15010204
Rios-Leyvraz, M., & Montez, J. (2022). Health effects of the use of non-sugar sweeteners: A systematic review and meta-analysis. World Health Organization. https://www.who.int/publications/i/item/9789240046429
Toews, I., Lohner, S., Küllenberg de Gaudry, D., Sommer, H., & Meerpohl, J. J. (2019). Association between intake of non-sugar sweeteners and health outcomes: Systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies. BMJ, 364, k4718. https://doi.org/10.1136/bmj.k4718
Witkowski, M., Nemet, I., Alamri, H., Wilcox, J., Gupta, N., Nimer, N., Haghikia, A., Li, X. S., Wu, Y., Saha, P. P., Demuth, I., König, M., Steinhagen-Thiessen, E., Cajka, T., Fiehn, O., Landmesser, U., Tang, W. H. W., & Hazen, S. L. (2023). The artificial sweetener erythritol and cardiovascular event risk. Nature Medicine, 29(3), 710-718. https://doi.org/10.1038/s41591-023-02223-9
Witkowski, M., Nemet, I., Li, X. S., Wilcox, J., Ferrell, M., Alamri, H., Gupta, N., Wang, Z., Tang, W. H. W., & Hazen, S. L. (2024). Xylitol is prothrombotic and associated with cardiovascular risk. European Heart Journal, 45(27), 2439-2452. https://doi.org/10.1093/eurheartj/ehae244
World Health Organization. (2023). Use of non-sugar sweeteners: WHO guideline. https://www.who.int/publications/i/item/9789240073616
NS455 Unit 7 instructions, in plain terms
Unit 7 of NS455 has students assemble and judge the sources a later trend paper will stand on. Prompts generally set a number of sources and ask for evaluation as well as summary. State the question the sources will serve before listing them. Choose sources that cover different kinds of evidence: cohorts, trials, mechanistic work, reviews and guidelines. For each, give the full APA 7 reference, then a short annotation covering design, main finding, a specific strength, a specific limit and how you will use it. Avoid repeating the abstract. Point out where sources conflict or where one changes how another should be read. Close with a short section on how the sources fit together and what evidence is still missing. Keep annotations to roughly the length the prompt suggests.
How this NS455 Unit 7 example is built
The sample opens with the planned paper's question and the logic for choosing sources. Annotations run alphabetically by first author. The French cohort is described with its repeated dietary records and its 9 percent risk finding, then limited by its observational design. The metabolomics study is flagged as essential because it shows the body makes erythritol. A highlighted sentence notes that no source is a long controlled trial on heart events. The 2023 erythritol paper gets the fullest annotation, with its hazard ratios, platelet work and eight-person feeding study. The xylitol paper is marked as the same group's work, not independent replication. The WHO review and guideline are annotated with their exclusion of sugar alcohols. A synthesis section and a list of evidence still needed close the bibliography.
Where the points sit in the NS455 Unit 7 rubric
Annotated bibliographies at this level are usually graded on source quality and variety, evaluative depth, accurate references and evidence of synthesis. Most credit tends to go to annotations that judge the source, naming a specific limitation and its consequence, rather than summarizing. Variety of evidence types shows a deliberate search. Instructors notice when a source's role in the planned paper is stated clearly. Pointing out how one source changes the reading of another, such as endogenous erythritol complicating blood-level studies, demonstrates synthesis. A closing section on gaps earns credit. References must be complete and correctly formatted in APA 7. Annotations that copy abstract language or exceed the length limit tend to lose points.
Common NS455 Unit 7 mistakes, and how to avoid them
The most common bibliography problem is annotations that only summarize, giving the finding but no evaluation. Another is a narrow search, with every source reaching the same conclusion. Writers often treat a narrative review as equal to a systematic one. Guidelines are cited without noting their scope, such as which sweeteners they cover. Sources by the same research group are presented as independent confirmation. The connection to the planned paper is left unstated. References are incomplete or formatted inconsistently. If you have a stack of sources but your annotations read like abstracts, a writer can help you evaluate each one and show how they fit together.
Get an NS455 Unit 7 example written to your instructions
Which trend or claim does your Unit 7 bibliography cover, how many sources does the prompt require, and which citation style? Send those with the rubric. Each annotation evaluates rather than summarizes, states the source's limits specifically, and names the role it will play in the paper still to come. Delivery is 24-48h, with the first sample free. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More NS455 papers and BS in Nutrition Science samples
- NS455 Unit 1: Sugar and Hyperactivity Post
- NS455 Unit 2: Late Eating Headline Critique
- NS455 Unit 3: Ultra-Processed Diet Trial Appraisal
- NS455 Unit 4: Eating Window Trend Comparison
- NS455 Unit 5: Blue Zones Seminar Reflection
- NS455 Unit 6: Glucose Monitor Fact Sheet
- NS455 Unit 8: Position Statement
- NS455 Unit 9: Journal Club Summary
- NS455 Unit 10: Trends Synthesis Paper
- NS420 Unit 7: DAP Client Case Note
- NS410 Unit 7: Menu and Session Plan
- NS325 Unit 7: High School Lunch Brief
- NS310 Unit 7: Six-Sign Observation
NS455 Unit 7 questions, answered
How long should each annotation be?
Whatever the prompt sets; where it is open, 100 to 150 words is common. Length matters less than content: design, finding, a specific limitation and the source's role in the argument. An annotation that covers those four in 90 words beats one that fills 200 with summary. Keep the length roughly consistent across entries so none looks neglected.
Can a news article appear in an annotated bibliography?
Yes, if its role is clear. A news piece can document how a finding was reported or what the public was told, which may matter to the argument. It cannot stand in for the study it describes. Label it as coverage in the annotation and pair it with the primary source so the reader sees both.
Should the sources disagree with each other?
Ideally some do. A bibliography where every source reaches the same conclusion often reflects a narrow search rather than a settled question. Include the strongest evidence on each side and let the annotations explain why they differ, whether by design, population or outcome. That tension usually becomes the most useful material for the paper that follows.
Where can I find a free NS455 Unit 7 sample paper?
This page has a full Unit 7 annotated bibliography of eight sources on sugar substitutes and heart risk, from the erythritol cohort study to the WHO guideline, each evaluated for what it can and cannot establish.
Why does the NS455 Unit 7 sample include a study on how the body makes erythritol?
Because blood erythritol can come from the body's own metabolism of glucose, not only from food. That means studies measuring blood levels may not reflect intake, which changes how the cardiovascular findings should be read.